Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
July 5, 2017 – GlaxoSmithKline (GSK) announced the permanent discontinuation and market withdrawal of Potiga (ezogabine) tablets due to the limited use of the medicine.
